Brief comparison between practices in screening in different developed countries along with developing countries like bangladesh and india done. The factors hindering screening programs in developing countries sought. Existing resources mentioned.
Practices of Cancer Screening In developed and developing countries
1. Practices of Cancer Screening in
Abroad and Bangladesh
Julfikar Saif
Resident
Department of Oncology
BSMMU
2. What is Screening?
• Screening is defined as the presumptive
identification of unrecognized disease in an
apparently healthy, asymptomatic population
by means of tests, examinations or other
procedures that can be applied rapidly and
easily to the target population.
4. Ideal Criteria of introducing population
screening
• The condition should be an important health problem
• Natural history of the condition should be adequately
understood
• There should be a recognizable latent or asymptomatic
stage
• There should be a suitable test or examination that has
a high level of accuracy
• The test should be acceptable to the population
5. Continued…
• Acceptable treatment available for disease
• There should be an agreed policy on whom to treat as
patients
• Facilities for diagnosis & treatment should be available
• The cost of screening+diagnosis+treatment should be
realistically feasible
• Screening should be a continuing process and not a
‘once and for all’ project.
6. Background
• In 1907, Dr. Charles Childe published a book entitled The Control of a Scourge, Or
How Cancer Is Curable. In it, he described the high mortality rates due to cancer as
tragically unnecessary, and put “the finger on the flaw”
• In the 1920s, The American Medical Association (AMA) endorsed use of the
periodic health exam for early detection of a number of diseases including cancer
• The test was invented by and named after the Greek-American doctor Georgios
Papanikolaou, who started his research in 1923
• American Society for the Contol of Cancer (ASCC) in 1913. The ASCC would change
its name to the American Cancer Society in 1945. The Women’s Field Army of the
ASCC was formed in the 1930s.5 This army of 150,000 women went neighborhood
by neighborhood teaching the virtues of early detection of cancer (Figure 1). The
Field Army focused on educating the public on the early warning signs of cancer
and breast self-examination.
• By mid1940s pap smear program showed its benefits of early detection with
nationwide adoption by 1960s
8. Cancer Screening in USA
• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
9. Breast Cancer
Age Group Investigation Recommendation
40-44 year
women
Mammography Women should be given
choice/opportunity to start
annual screening
45-54 years
women
Mammography Annual screening
At or above
55 years
women
Mammography Biennial screening
May choose annual screening
Continue until one has 10
year life expectancy
10. Cervical Cancer
Age Group Investigation Recommendation
21-29 years
women
Pap test Should start from 21 years, 3
yearly
30-65 years
women
Pap test and HPV
DNA test
Both test 5yearly is
preferred, 3yearly pap only is
acceptable
>65 years women Pap test and HPV
DNA test
May stop if 3 or more
negative pap only or 2 or
more pap+DNA test negative
if last negative test within
5years
Women who
underwent total
hysterectomy
Stop screening
11. Endometrial Cancer
Age group Intervention Recommendation
Women at
menopause
At the time of
menopause, women
are informed about
risks and symptoms
of endometrial
cancer and strongly
encouraged to
report any
unexpected
bleeding or spotting
to their physicians
12. Colorectal Cancer
Age group Intervention Recommendation
45-75 years FIT/FOBT annually or
Multitarget stool DNA
3yearly or CT
colonography/flexible
sigmoidoscopy 5 yearly or
colonoscopy 10yearly
Test is selected as per
patient’s choice, if any
non colonoscopy test
76-85years Individualize
decisission according
to patient’s choice, life
expectancy etc
>85 years Should be discouraged
from screening
13. Lung Cancer
Age Group Investigation Recommendation
Current or
former smokers
aged 55‐74 y in
good health
with at least a
30–pack‐y
history of
smoking
Low‐dose
helical CT
Annual screening if,
#current smoker or quitted within
past 15 years and
#30 pack year smoking and
#Receive evidence based smoking
cessation advice if current smoker
and
#Knows risk-benefit of screening test
and gave informed consent and
#has access to high quality high
volume screening and treatment
center
14. Prostate cancer
Age Group Investigation Recommendation
Men at or above 50
years
PSA with or without DRE Men with at least 10
year life expectancy
after knowing all the
risk-benefit and
uncertainties associated
with such screening are
presented with
opportunity to choose
to go for screening or
not
16. Cervical Cancer
Group Investigation Recommendatio
n
25-49 years
women and trans
men
HPV and Liquid
Based Cytology
3 yearly
50-64 years
women and trans
men
HPV and Liquid
Based Cytology
5 yearly
17. Breast Cancer
Group Investigation Recommendation
50-70 years women Mammography 3 yearly for 7 total visits
usually
>70 years women Mammography May choose to continue
3yearly breast screening
but has to make own
appointment
18. Colorectal Cancer
Group Investigation Recommendation
50/60-74 years *FIT/FOB 2 yearly
55 year Colonoscopy One off test, only
practiced in England
Above 74 years May ask for FIT kit 2
yearly
19. Cancer screening under NHS
• Lung cancer
– NHS is starting lung cancer screening under the
umbrella of lung health check up in some parts of
UK from autumn 2019
• Prostate cancer
– No national program as NHS regards current tests
unreliable and doesn’t reduce mortality
20. Cancer screening in Japan
• Gastric Cancer
• Lung Cancer
• Colorectal Cancer
• Breast Cancer
• Cervical Cancer
21. Gastric Cancer
Group Investigation Recommendation
>50 years Endoscopy of upper
GI
Gastric X ray
examination
2-3 yearly
Pepsinogen method
Helicobacter Pylori
detection
At the discretion of
subject
22. Lung Cancer
Group Investigation Recommendation
>40 years Chest Xray ± Sputum
cytology
CXR only for Non high
risk group
Both for high risk
group
LDCT Not recommended
but maybe performed
based on subject’s
choice
24. Cancer screening in India
• Place?
– Community health center / Sub-center / Primary
health center
• Personnel?
– Auxiliary Nurse Midwife/Mid level providers/Nurse
25. Continued…
Type of
cancer
Age Method of
Screening
Frequency
of
Screening
If Positive
Oral 30-65
years
Oral Visual
Examination
(OVE)
5yearly
Referred to ENT
specialist/surgeon/dentist/MO for
confirmation if needed biopsy
Cervical 30-65
years
Visual
Inspection
With acetic
acid (VIA)
Referred to facilities where
gynaecologist or trained lady
medical officer available
Breast 30-65
years
Clinical
breast
Examination
Referred surgeon for confirmation
using breast USG followed by
biopsy as appropriate
26. Continued…
• Cost?
– For VIA- examination lamp, Cusco’s speculum,
autoclave, torch = 20000 Rs.
– For OVE- Mouth mirror, LED torch = 3000 Rs
– Consumables for VIA- gloves, cotton swab,
distilled water, acetic acid= 10 Rs/capita
– For OVE- wooden stick, glove, cotton, gauze= 10Rs
per capita
30. Continued…
• Timeline
– In 2005 government adopted opportunistic
cervical cancer screening at district level
– In 2006 National Cervical and Breast Cancer
Screening Program launched with strong support
from BSMMU and UNFPA
– From 2012 the program is being extended to
Upazila
33. Continued…
• Place?
– BSMMU
– All medical college hospitals
– District Hospital
– Maternal Child Welfare Centers
– Selected Upazila Health Complexes
– Some NGO clinics by trained Family Welfare
Visitors/Paramedics/Doctors
34. Continued…
• Available facilities and technologies
– Breast Cancer- Mammography, USG
– Lung Cancer- Chest radiograph
– Colorectal Cancer- FIT, FOBT, Structural Visual
Examination
– Prostate Cancer- PSA
– Gastric Cancer- UGI endoscopy, Radiograph
35. Challenges foreseen by healthcare workers in
implementation of population cancer screening
program at Silchar Assam